Holden Leads Blog
Data, outreach strategies, and market intelligence for cannabis B2B professionals.
TerrAscend's Michigan assets are in receivership over $210M owed to one lender. Inside Michigan's cannabis shakeout and what the churn means for vendors.
Read more →The DEA cannabis rescheduling hearing wrapped July 15 after 17 days. Next milestone: post-hearing briefs due August 17. Here's the timeline from here.
Read more →Selling to cannabis MSOs is a different job than selling to independent dispensaries. How buying decisions differ, and how to work each motion.
Read more →Cannabis B2B outreach channels compared: where email deliverability breaks, when phone works, and why direct mail overperforms with dispensary buyers.
Read more →Trulieve and Glass House both trade below their NYSE debut prices a month in. What the first weeks of cannabis stocks on the NYSE actually signal.
Read more →Georgia's SB 220 took effect July 1. What its milligram caps and hemp crackdown say about where the cannabis edibles market is heading in 2026.
Read more →Virginia opened adult-use licensing, Missouri set a 77-license lottery, and Georgia expanded medical sales. The July 1 dispensary rule changes that matter.
Read more →B2B contact data decays 22-35% a year, and cannabis churns faster. Here's what actually breaks a dispensary contact list and how to tell if yours is dead.
Read more →Glass House hit the NYSE, Vireo paid $20M to enter Pennsylvania, and the Teamsters struck a grow. The week in cannabis deals and what it signals for B2B.
Read more →Pre-rolls overtook flower as cannabis's top category by units in 2026, led by infused pre-rolls. Here's the data and what the shelf shift means for B2B sellers.
Read more →Holden Leads
Phone, email, website and licence data for dispensaries, cultivators, manufacturers, distributors and labs, verified weekly against state regulators.